Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
DCOY
DCOY
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DCOY News
Decoy Therapeutics Nominates New Director
Jun 03 2026
PRnewswire
Decoy Therapeutics Partners with hVIVO for D-MAV Clinical Development
Jun 01 2026
NASDAQ.COM
Decoy Therapeutics Initiates Clinical Studies for New Antiviral Category
Jun 01 2026
PRnewswire
Decoy Appoints New Chair of Scientific Advisory Board
May 26 2026
PRnewswire
Biotech Stocks Surge with Akari Leading the Rally
May 26 2026
NASDAQ.COM
Decoy Therapeutics Showcases Novel Antiviral Therapies in Boston
Apr 27 2026
PRnewswire
Decoy Therapeutics Launches Multi-Virus Antiviral Platform
Apr 09 2026
PRnewswire
Decoy Therapeutics Launches Multi-Viral Antiviral Platform
Apr 09 2026
Newsfilter
Decoy Therapeutics CEO to Participate in Investor Event
Apr 06 2026
PRnewswire
Decoy Therapeutics CEO to Participate in Investor Event
Apr 06 2026
Newsfilter
Decoy Partners with Quantori to Enhance Antiviral Drug Design Capacity
Mar 11 2026
PRnewswire
Decoy Partners with Quantori to Enhance Antiviral Drug Design Capacity
Mar 11 2026
Newsfilter
Decoy Therapeutics to Execute 1-for-12 Reverse Stock Split
Mar 05 2026
seekingalpha
Decoy Therapeutics Announces 1-for-12 Reverse Stock Split
Mar 05 2026
PRnewswire
Decoy Therapeutics to Participate in Corporate Connect Webinar
Feb 05 2026
PRnewswire
Decoy Therapeutics Partners with Gates Foundation on Global Access Commitment
Feb 04 2026
PRnewswire
Show More News
